Haemonetics Corp

Ownership Transactions Reported by 22 Insiders

Symbol
HAE on NYSE
Location
125 Summer Street, Boston, MA

Insiders trading volume in the past year

Haemonetics Corp executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Christopher Simon President & CEO, Director $24.4M Aug 29, 2024
Josep Llorens EVP, Global Manufacturing $2.96M -$246K -7.66% May 28, 2024
Michelle L. Basil EVP and General Counsel $2.77M -$1.49M -35% May 28, 2024
William Burke EVP, Chief Financial Officer $2.62M Aug 23, 2021
Charles J. Dockendorff Director $2.01M Jul 25, 2024
Robert E. Abernathy Director $2.01M Jul 25, 2024
Anila Lingamneni EVP, Chief Technology Officer $1.92M -$418K -17.9% Jul 11, 2024
Mark W. Kroll Director $1.86M Jul 25, 2024
Laurie A. Miller SVP, Human Resources $1.73M May 28, 2024
Catherine M. Burzik Director $1.69M Aug 5, 2022
James DArecca EVP, Chief Financial Officer $1.66M May 17, 2024
Stewart W. Strong President, Global Hospital $1.66M -$1.3M -44% Jul 26, 2024
Ellen M. Zane Director $1.5M Jul 25, 2024
Chad M. Nikel President, Global Plasma & BC $1.5M Aug 6, 2021
Claire Pomeroy Director $1.28M Jul 25, 2024
Michael J. Coyle Director $1.14M Jul 25, 2024
Lloyd Emerson Johnson Director $922K Jul 25, 2024
Roy Galvin President, Global Plasma & BC $705K May 17, 2024
Diane M. Bryant Director $399K Jul 25, 2024
Dan Goldstein VP, Corporate Controller $384K Jun 13, 2022
Jacqueline Scanlan SVP, Global Human Resources $364K Jun 7, 2021
Farris Maryanne Maunsell VP, Chief Accounting Officer $109K May 17, 2024

Recent Insider Transactions by Companies or Individuals for Haemonetics Corp

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.